medical abortion.
Conditions
Interventions
Intervention 1: Pregnant women with a gestational age of less than 14 weeks based on last menstural period (LMP) who are candidates for medical abortion and will take 10 mg of Letrozole daily for 5 da
Sponsors
Shahid Beheshti University of Medical Sciences
Eligibility
Sex/Gender
Female
Inclusion criteria
Inclusion criteria: Any Pregnant Women with Gestational Age Less than 14 Weeks Candidate for Medical Abortion with No Serious Comorbidities No Recent or Recurrent Use of Corticosteroids No History of and Allergy to Letrozol No History of and Allergy to Misoprostol Hemoglobin more than 10 Normal Coagulation and Complete blood count (CBC) test
Exclusion criteria
Exclusion criteria: Recurrent Abortion with Gestational Age Less than 14 weeks
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Complete Abortion Rate. Timepoint: Trans Vaginal Sonography for Remnant of Production will be Done in Patients Who Dispose of Pregnancy Products. Method of measurement: Complete Disposal of Pregnancy Products before 20 Weeks Gestational Age.;Incomplete Abortion Rate. Timepoint: Trans Vaginal Sonography for Remnant of Production will be Done in Patients Who Dispose of Pregnancy Products. Method of measurement: Incomplete Disposal of Pregnancy Products before 20 Weeks Gestational Age.;Amount of Vaginal Bleeding. Timepoint: 6 Hours Before and 6 Hours After Disposal of Pregnancy Products. Method of measurement: Number of Pads Used in an our.;Surgical Curettage Rate. Timepoint: When Incomplete Abortion Occur after Receiving One Course of Misoprostol based on FIGO Protocol. Method of measurement: The Number of Patients who Underwent Surgical Curettage. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactZahra Najjari
Shahid Beheshti University of Medical Sciences
Outcome results
None listed